Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.31 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.31 |
| ▸ | KCNQ4 | P56696 | 1/20 | 0.31 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 2/20 | 0.30 |
| ▸ | JAK1 | P23458 | 2/20 | 0.30 |
| ▸ | TYK2 | P29597 | 2/20 | 0.30 |
| ▸ | JAK3 | P52333 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20358070 | 1.00 | MEN1 (0.38) | MEN1POLBGAAKMT2AKCNQ3 | |
| SCHEMBL27255189 | 0.81 | MEN1 (0.44) | MEN1POLBGAAKMT2A | |
| SCHEMBL20358086 | 0.73 | HIF1A (0.40) | — | |
| SCHEMBL21085331 | 0.72 | MEN1 (0.46) | MEN1POLBGAAKMT2AKCNQ3 | |
| SCHEMBL20358182 | 0.71 | MEN1 (0.45) | MEN1POLBGAAKMT2AKCNQ3 | |
| SCHEMBL20375427 | 0.71 | MEN1 (0.45) | MEN1POLBGAAKMT2AKCNQ3 | |
| SCHEMBL24337701 | 0.71 | — | — | |
| SCHEMBL11910688 | 0.71 | LPL (0.45) | — | |
| SCHEMBL4020523 | 0.71 | LPL (0.45) | — | |
| SCHEMBL30573087 | 0.69 | JAK2 (0.33) | MEN1POLBGAAKMT2AJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11201298-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-12-14 | — | — | US | disclosed |
| US-20180198079-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-07-12 | — | — | US | disclosed |
| US-20180198079-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180198079-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP | MEN1 4543/4885POLB 934/4885GAA 3502/4885 |
| US-11201298-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | MEN1 4543/4885POLB 934/4885GAA 3502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.